Skip to main content
    O

    OrganiGram Holdings Inc (OGI)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $0.72
    -0.11 (-12.71%)

    Market Cap: $116.93M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Earnings

    Upcoming Estimates

    Reports Dec 15, 2026 (est.)Period ending Sep 30, 2026
    EPS ConsensusN/A
    RangeN/A
    Revenue Consensus
    N/A
    RangeN/A
    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus0.01
    Range0.01 - 0.01
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago0.00n/a
    60d ago0.010.0%
    30d ago0.010.0%
    7d ago0.010.0%
    Current0.01
    Revenue Consensus
    110.82M
    Range105.10M - 116.53M
    2 analysts
    Last 12 of 39 reported quarters and 2 upcoming estimates
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    Date TBD
    -0.010.01 - 0.01--1
    No revisions (30d)
    -
    Sep 26EST
    Exp. Dec 15
    -N/AN/A-----
    Jun 26
    Reported Aug 11
    -0.05-0.01-0.01 - 0.00--3
    No revisions (30d)
    -
    Mar 26
    Reported May 12
    -0.010.00-0.01 - 0.00--2
    No revisions (30d)
    -
    Dec 25
    Reported Feb 10
    -0.01-0.01-0.01 - -0.01--1
    No revisions (30d)
    -
    Sep 25
    Reported Dec 16
    -0.28-0.01-0.01 - -0.01--1
    0
    1
    30d
    -
    Jun 25
    Reported Aug 13
    -0.01-0.01-0.01 - -0.01--1
    0
    1
    30d
    -
    Mar 25
    Reported May 12
    0.24-0.03-0.03 - -0.03--1
    No revisions (30d)
    -
    Dec 24
    Reported Feb 11
    -0.11-0.02-0.02 - -0.02--1
    No revisions (30d)
    -
    Sep 24
    Reported Dec 18
    -0.10-0.04-0.04 - -0.04--1
    1
    0
    30d
    -
    Jun 24
    Reported Aug 13
    0.02-0.05-0.06 - -0.04--3
    No revisions (30d)
    -
    Mar 24
    Reported May 14
    -0.08-0.07N/A-----
    Dec 23
    Reported Feb 13
    -0.14-0.10N/A-----
    Sep 23
    Reported Dec 19
    -0.37-0.02N/A-----

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDA8.13x
    Price/FCF-4.26xFCF Yield-23.45%
    Profitability
    Profit Margin28.00%Operating Margin-2.16%
    ROE17.60%ROIC-1.21%
    Financial Health
    Debt/Equity0.04xInterest CoverageN/A
    Current Ratio2.61xQuick Ratio1.07x
    Trading Statistics
    Beta1.98Avg Volume624.26K
    52-Week High$2.2452-Week Low$0.80

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 25.7% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 21.9, below 30, the oversold line.

    Moving Averages

    SMA 10$0.87
    SMA 20$0.90
    SMA 50$0.97
    SMA 200$1.16
    EMA 10$0.85
    EMA 20$0.89
    EMA 50$0.96
    EMA 200$1.15

    MACD

    Line: -0.05Signal: -0.03Hist: -0.01

    ADX

    ADX: 38.9+DI: 5.9-DI: 37.3

    Aroon & PSAR

    Aroon Up72.0
    Aroon Down100.0
    PSAR$0.95

    Bollinger Bands

    Upper Band$1.03
    Lower Band$0.78
    %B Position2712%(Upper)
    Band Width-0.24

    RSI (14-Day)

    Oversold
    21.9

    Momentum Oscillators

    Stoch %K9.2
    Stoch %D8.6
    Williams %R-95.1
    ROC (10d)-25.1%
    Momentum-0.24
    CCI (20d)-240.9
    MFI (14d)23.8

    Volatility Measures

    ATR (14d)$0.05(6.9%)
    StdDev (20d)0.06
    Hist Vol59.0%(High)

    Volume Flow

    VWAP$0.75
    OBV-6.1M
    AD Line2.3M
    CMF (20d)-0.086

    Volume Metrics

    Avg Vol (20d)639.3K
    Vol Ratio1.8x(High)
    VWMA (20d)$0.90

    Pivot Points

    R3$0.89
    R2$0.86
    R1$0.85
    Pivot Point$0.82
    S1$0.81
    S2$0.78
    S3$0.77

    Advanced Oscillators

    TSI-32.74
    Ultimate Osc29.6
    KST-105.71

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about OGI

    News

    OGI Valuation

    GNG's valuation label for OGI is Undervalued.

    EV/EBITDA
    8.1x
    P/FCF
    -4.3x
    P/B
    0.3x
    OGI valuation multiples

    OGI Profitability: Margins, ROIC and FCF

    OrganiGram Holdings (OGI) has a gross margin of 36.5%, an operating margin of -2.2% and a net margin of 28.0%. It posts -1.2% ROIC.

    Gross margin
    36.5%
    Operating margin
    -2.2%
    Net margin
    28.0%
    ROIC
    -1.2%
    ROE
    17.6%
    FCF yield
    -23.5%
    OGI financial statements

    OrganiGram Holdings Competitors

    The companies most similar to OrganiGram Holdings (OGI) include Organogenesis Holdings, Canopy Growth and Cardiol Therapeutics Inc Class A.

    Sector: Healthcare

    Companies most similar to OrganiGram Holdings

    OGI Analyst Ratings

    OrganiGram Holdings (OGI) has a Buy consensus from 5 analysts: 4 Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    5
    Strong Buy
    1
    Buy
    3
    Hold
    1
    Sell
    0
    Strong Sell
    0

    OGI Bull Case vs Bear Case

    Bull case

    • OGI has a 28.0% net profit margin.
    • OGI grew quarterly revenue 49.4% year over year.
    • 80.0% of OGI's analyst ratings are Buy or Strong Buy.

    OGI Earnings Date

    OGI reports Dec 15, 2026. The date is estimated.

    OGI Earnings Call

    The latest OGI earnings call transcript on file is labeled 2026Q1.

    Read the 2026Q1 transcript

    OGI ETF Holders

    Updated Aug 15, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About OGI

    When does OGI report earnings?

    OrganiGram Holdings Inc (OGI) is expected to report earnings on Dec 15, 2026.

    Does OGI pay dividends?

    OrganiGram Holdings Inc (OGI) does not currently pay a regular dividend.

    What is OGI's market cap?

    OrganiGram Holdings Inc (OGI) has a market capitalization of $116.93M with a current stock price of $0.72.

    How do analysts rate OGI stock?

    5 analysts cover OrganiGram Holdings Inc (OGI): 1 rate it Strong Buy, 3 Buy, 1 Hold, 0 Sell and 0 Strong Sell, a consensus of Buy.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.